This week’s newsletter covers the latest plant medicine research, including hemp flour’s nutritional benefits in baking, myrcene’s neuroprotective potential, engineered fungi producing cannabinoids, and cannabinoid combinations showing promise for neuropathy and inflammatory bowel disease. Noteworthy […]
This week’s newsletter covers surprising findings on cannabis use and cognitive performance in older adults, the industry and policy fallout from the new federal hemp THC ban, a challenge to the “mature brain at 25” […]
This week’s newsletter covers a federal cannabis seed ban threatening to push genetics underground, the science of terpenes activating cannabinoid receptors, psychedelics and elite capitalism, safety concerns in the mushroom edibles market, and new research […]
This week’s newsletter covers Trump’s executive order directing cannabis rescheduling to Schedule III, federal enforcement challenges around intoxicating hemp products, new research on cannabinoids and ovarian cancer, sleep quality, obesity, cardiovascular health, and a rare […]
This week’s newsletter covers cannabis rescheduling, hemp regulation enforcement hurdles, promising cannabinoid research for Alzheimer’s disease and hypertension, CBD use trends on college campuses, the environmental toll of drug prohibition, and the WHO’s new push […]
This week’s newsletter covers the uncertain fate of cannabis rescheduling under the Trump administration, along with new research on psychedelic polypharmacy, psilocybin’s role in fear extinction and cancer-related depression, and the psychological aftermath of intense […]
This week’s newsletter explores how psychedelic experiences can fuel scientific breakthroughs, alongside a roundup of recent research on CBD’s therapeutic potential across chronic pain, inflammatory bowel disease, Alzheimer’s, cancer, and heart health. Noteworthy Read The […]
This week’s newsletter covers new research on cannabis for treatment-resistant depression, CBD’s potential in cardiovascular health and traumatic brain injury recovery, the therapeutic promise of acidic cannabinoids like THCA and CBDA, and an unexpected interaction […]
This week’s newsletter covers the latest research and journalism on plant medicine, including a landmark study on psilocybin microdosing and creativity, debates over non-hallucinogenic psychedelics, neuroplasticity and addiction treatment, quality control in the psychedelic products […]
This week’s newsletter covers new findings on cannabis and cognitive performance in older adults, the challenges posed by semi-synthetic cannabinoids, CBD’s potential effects on bone health and fetal alcohol spectrum disorder, hemp extract’s role in […]
© Copyright 2018-2026 HempEtCetera.com, Hemp Et Cetera™ is a unit of SoCal Broadband Inc. All rights reserved.